{
  "paper_metadata": {
    "pmid": "32522261",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information specifically for the BRCA2 gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.658_659delG",
      "protein_notation": "p.Val220fs",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "female, breast cancer",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 2,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "BRCA2 (p.Val220fs) was identified in women affected by breast cancer."
        }
      ],
      "functional_data": {
        "summary": "The variant is a frameshift mutation leading to a premature stop codon.",
        "assays": []
      },
      "segregation_data": "Yes, it segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "Strong evidence based on clinical correlation.",
      "source_location": "Table 2, Row 3",
      "additional_notes": "This variant was one of the pathogenic variants identified in the study.",
      "key_quotes": [
        "BRCA2 (p.Val220fs) was identified in women affected by breast cancer."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.2808_2811delACAA",
      "protein_notation": "p.Ala938fs",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "female, breast cancer",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 2,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "BRCA2 (p.Ala938fs) was identified in women affected by breast cancer."
        }
      ],
      "functional_data": {
        "summary": "The variant is a frameshift mutation leading to a premature stop codon.",
        "assays": []
      },
      "segregation_data": "Yes, it segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "Strong evidence based on clinical correlation.",
      "source_location": "Table 2, Row 4",
      "additional_notes": "This variant was one of the pathogenic variants identified in the study.",
      "key_quotes": [
        "BRCA2 (p.Ala938fs) was identified in women affected by breast cancer."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 2",
      "table_caption": "Pathogenic variants (PV)",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data for BRCA2 variants were extracted successfully."
  }
}